Cspc Zhongqi Pharmaceutical Technology Co., Ltd.
Clinical trials sponsored by Cspc Zhongqi Pharmaceutical Technology Co., Ltd., explained in plain language.
-
New Weight-Loss shot SYH2082 enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a single dose of an investigational injection called SYH2082 in 44 healthy adults who are overweight or obese. The main goal is to check if the drug is safe and tolerable. Participants will be randomly assigned to receive either the drug or a placebo,…
Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
New hope for advanced liver cancer: experimental combo targets tumors directly
Disease control Not yet recruitingThis study tests a new treatment for people with advanced liver cancer that has not improved after initial therapy. The treatment delivers a chemotherapy drug directly into the liver's blood supply, combined with other medications given through the body. The goal is to see if thi…
Phase: PHASE1, PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New hope for kids with rare MMA: B12 shot trial begins
Disease control Not yet recruitingThis study tests a vitamin B12 injection (hydroxocobalamin) in 20 children aged 6 months to 18 years with a rare genetic condition called methylmalonic acidemia (MMA) with high homocysteine. The goal is to see if the injection can normalize acid levels in the blood or urine. Part…
Phase: PHASE3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC